Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2023-03-29 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
关于苏州广慈肿瘤医院有限公司2022年度承诺业绩实现情况的鉴证报告
Audit Report / Information Classification · 95% confidence The document is a verification report (鉴证报告) issued by an accounting firm regarding the performance commitment achievement of Suzhou Guangci Tumor Hospital Co., Ltd. for the year 2022. It references compliance with the China Securities Regulatory Commission's rules on major asset restructuring and includes detailed financial performance commitments and their fulfillment. The document is not a full annual report but a standalone audit/verification report focused on a specific performance commitment related to a major asset acquisition. The length is about 3,320 characters, which is consistent with a standalone audit or verification report rather than a full annual or interim report. Therefore, it fits best under the category of Audit Report / Information (AR). FY 2022
2023-03-29 Chinese
独立董事2022年度述职报告（卢军）
Board/Management Information Classification · 95% confidence The document is a detailed annual report by an independent director of a company, describing their duties, attendance at board and shareholder meetings, opinions on various company matters, committee work, investigations, investor protection efforts, training, and other activities during the year 2022. It includes specific dates, meeting numbers, and detailed descriptions of the director's work and opinions on company governance and financial matters. The document is not a brief announcement or a certification but a substantive report on the director's activities and governance role over the year. This fits the category of Board/Management Information (MANG), which covers announcements of changes or reports related to the company's board or senior management activities. The length and detail confirm it is not a simple announcement or regulatory filing. Therefore, the classification is MANG with high confidence.
2023-03-29 Chinese
2022年年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an "审计报告" (Audit Report) for 盈康生命科技股份有限公司, with a specific audit report number and date (2023). It contains detailed audit opinions, basis for audit opinions, key audit matters, management responsibilities, and auditor responsibilities. It includes comprehensive financial statements and notes, such as consolidated balance sheets, profit and loss statements, cash flow statements, and shareholders' equity changes. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The content is consistent with a standalone audit report rather than a full annual report or other filing types. Therefore, the document fits the category of Audit Report / Information (AR). FY 2022
2023-03-29 Chinese
关于2022年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a special report on the storage and use of raised funds for the year 2022 by 盈康生命科技股份有限公司. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange regarding the management and use of raised funds. The content details the amount of funds raised, usage during the reporting period, storage, management, and compliance with regulatory requirements. The document length is 3755 characters, which is relatively short but contains detailed financial data about fundraising and its usage, not just an announcement or a certification. This matches the characteristics of a Capital/Financing Update (CAP) report, which covers updates on company fundraising and capital structure changes. It is not an Annual Report, Interim Report, or Earnings Release, as it focuses specifically on fundraising and use of proceeds. Therefore, the appropriate classification is CAP with high confidence.
2023-03-29 Chinese
2022年年度报告
Annual Report Classification · 100% confidence The document is titled as the full 2022 Annual Report of 盈康生命科技股份有限公司 (INKON Life Technology Co., Ltd.). It contains detailed sections typical of an annual report, including company overview, financial data, management discussion and analysis, governance, social responsibility, and financial statements. The text includes comprehensive financial figures for the fiscal year 2022, comparisons with previous years, detailed business and industry analysis, and audit information. The length of the document (15,000 characters) and the depth of content confirm it is the full annual report, not just an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K). FY 2022
2023-03-29 Chinese
安信证券股份有限公司关于盈康生命科技股份有限公司2022年度募集资金存放与使用情况的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from a sponsoring securities company (安信证券股份有限公司) regarding the 2022 annual special verification opinion on the deposit and use of raised funds by 盈康生命科技股份有限公司. It includes specific financial figures about the amount raised, usage during the year, balance, management and storage of the funds, and verification opinions from an accounting firm. The document is focused on the use and management of capital raised through a non-public stock issuance, with no indication that it is an announcement or a brief summary. It is not a general annual report or earnings release but a specialized audit and verification report on fundraising and capital usage. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles related to specific financial activities, excluding full annual reports. The document length is 4440 characters, which is sufficient for a detailed report rather than a mere announcement. Therefore, the classification is AR with high confidence. FY 2022
2023-03-29 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.